The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review
Authors:
- Gary C. ChamnessGCGary C. Chamness
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Immunohistochemical Study on the Expression of c-erbB-2 Oncoprotein in Breast CancerOncology, 1994
- Cell biological factors associated with the response of breast cancer to systemic treatmentCancer Treatment Reviews, 1993
- Prognostic significance of c-erbB-2 expression in node negative breast cancerBritish Journal of Cancer, 1993
- Why do so many prognostic factors fail to pan out?Breast Cancer Research and Treatment, 1992
- Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neuBreast Cancer Research and Treatment, 1992
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.Journal of Clinical Oncology, 1992
- Association of C‐erbB‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancerInternational Journal of Cancer, 1991
- c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesBritish Journal of Cancer, 1991
- Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancerAnnals of Oncology, 1991
- An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinomaBritish Journal of Cancer, 1988